CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in geriatric population coupled with high prevalence of chronic diseases globally
3.4.2. Restraints
3.4.2.1. High cost of contrast injectors systems and high risk associated with contrast injector system
3.4.3. Opportunities
3.4.3.1. Surge in healthcare expenditure and emergence of complex diseases in developing countries
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Injector Systems
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Accessories
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Radiology
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Interventional Radiology
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Interventional Cardiology
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: CONTRAST INJECTOR SYSTEMS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Diagnostics centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Clinics
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Others
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
CHAPTER 7: CONTRAST INJECTOR SYSTEMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. U.K.
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2020
CHAPTER 9: COMPANY PROFILES
9.1. Bracco Imaging S.p.A
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Bayer Healthcare LLC
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. Guerbet Group
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. Medtron AG
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Ulrich GmbH & Co. KG
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. GE Healthcare
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Shenzhen Seacrown Electromechanical Co., Ltd.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Nemoto Kyorindo Co. Ltd.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Sino Medical- Device Technology Co., Ltd.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Vivid Imaging
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
TABLE 01. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02. CONTRAST INJECTOR SYSTEMS MARKET FOR CONSUMABLES, BY REGION, 2020-2030 ($MILLION)
TABLE 03. CONTRAST INJECTOR SYSTEMS MARKET FOR INJECTOR SYSTEMS, BY REGION, 2020-2030 ($MILLION)
TABLE 04. CONTRAST INJECTOR SYSTEMS MARKET FOR ACCESSORIES, BY REGION, 2020-2030 ($MILLION)
TABLE 05. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 06. CONTRAST INJECTOR SYSTEMS MARKET FOR RADIOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 07. CONTRAST INJECTOR SYSTEMS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 08. CONTRAST INJECTOR SYSTEMS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 09. GLOBAL CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 10. CONTRAST INJECTOR SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
TABLE 11. CONTRAST INJECTOR SYSTEMS MARKET FOR DIAGNOSTICS CENTERS, BY REGION, 2020-2030 ($MILLION)
TABLE 12. CONTRAST INJECTOR SYSTEMS MARKET FOR CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. CONTRAST INJECTOR SYSTEMS MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 14. CONTRAST INJECTOR SYSTEMS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 16. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 17. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 18. NORTH AMERICA CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 19. U.S. CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 20. U.S. CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 21. U.S. CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 22. CANADA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 23. CANADA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 24. CANADA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 26. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 27. MEXICO CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 28. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 29. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 30. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31. EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 33. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 34. GERMANY CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 36. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 37. FRANCE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38. U.K. CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 39. U.K. CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 40. U.K. CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41. ITALY CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 42. ITALY CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 43. ITALY CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 45. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 46. SPAIN CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 47. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 48. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 49. REST OF EUROPE CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 51. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 52. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53. ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 54. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 55. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 56. JAPAN CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57. CHINA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 58. CHINA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 59. CHINA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60. INDIA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 61. INDIA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 62. INDIA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 64. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 65. AUSTRALIA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 69. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 70. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 71. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 72. LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 73. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 74. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 75. BRAZIL CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 76. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 77. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 78. SAUDI ARABIA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 79. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 80. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 81. SOUTH AFRICA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 83. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 84. REST OF LAMEA CONTRAST INJECTOR SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85. BRACCO IMAGING S.P.A: KEY EXECUTIVES
TABLE 86. BRACCO IMAGING S.P.A: COMPANY SNAPSHOT
TABLE 87. BRACCO IMAGING S.P.A: PRODUCT SEGMENTS
TABLE 88. BRACCO IMAGING S.P.A: PRODUCT PORTFOLIO
TABLE 89. BAYER HEALTHCARE LLC: KEY EXECUTIVES
TABLE 90. BAYER HEALTHCARE LLC: COMPANY SNAPSHOT
TABLE 91. BAYER HEALTHCARE LLC: PRODUCT SEGMENTS
TABLE 92. BAYER HEALTHCARE LLC: PRODUCT PORTFOLIO
TABLE 93. GUERBET GROUP: KEY EXECUTIVES
TABLE 94. GUERBET GROUP: COMPANY SNAPSHOT
TABLE 95. GUERBET GROUP: PRODUCT SEGMENTS
TABLE 96. GUERBET GROUP: PRODUCT PORTFOLIO
TABLE 97. MEDTRON AG: KEY EXECUTIVES
TABLE 98. MEDTRON AG: COMPANY SNAPSHOT
TABLE 99. MEDTRON AG: PRODUCT SEGMENTS
TABLE 100. MEDTRON AG: PRODUCT PORTFOLIO
TABLE 101. ULRICH GMBH & CO. KG: KEY EXECUTIVES
TABLE 102. ULRICH GMBH & CO. KG: COMPANY SNAPSHOT
TABLE 103. ULRICH GMBH & CO. KG: PRODUCT SEGMENTS
TABLE 104. ULRICH GMBH & CO. KG: PRODUCT PORTFOLIO
TABLE 105. GE HEALTHCARE: KEY EXECUTIVES
TABLE 106. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 107. GE HEALTHCARE: SERVICE SEGMENTS
TABLE 108. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 109. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: KEY EXECUTIVES
TABLE 110. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 111. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCT SEGMENTS
TABLE 112. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 113. NEMOTO KYORINDO CO. LTD.: KEY EXECUTIVES
TABLE 114. NEMOTO KYORINDO CO. LTD.: COMPANY SNAPSHOT
TABLE 115. NEMOTO KYORINDO CO. LTD.: PRODUCT SEGMENTS
TABLE 116. NEMOTO KYORINDO CO. LTD.: PRODUCT PORTFOLIO
TABLE 117. SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: KEY EXECUTIVES
TABLE 118. SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 119. SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: PRODUCT SEGMENTS
TABLE 120. SINO MEDICAL- DEVICE TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
TABLE 121. VIVID IMAGING: KEY EXECUTIVES
TABLE 122. VIVID IMAGING: COMPANY SNAPSHOT
TABLE 123. VIVID IMAGING: PRODUCT SEGMENTS
TABLE 124. VIVID IMAGING: PRODUCT PORTFOLIO
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer